RxDoctor Payments DataLook up a doctor →

Kami Kim, MD

Infectious Disease · Tampa, FLNPI 1477638252

Payments from drug & device makers

$2,351,106in general payments, 2019–2025

Across 308 payments — averaging $7633.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron$2.2M
  • Pfizer$92K
  • Dompe Farmaceutici S.p.a.$31K
  • Astrazeneca UK Limited$27K
  • AstraZeneca$25K
  • Merck$3K
  • plus $6K from 5 others

What the payments were for

  • Consulting fees$4,39577%
  • Travel & lodging$3456%
  • Food & beverage$97617%

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Regeneron265$2,167,411
Pfizer19$91,723
Dompe Farmaceutici S.p.a.11$31,065
Astrazeneca UK Limited2$26,700
AstraZeneca1$24,721
Merck1$3,000
Abbott2$2,638
Shionogi Inc1$2,520
Biomerieux Inc4$1,143
Angiodynamics, Inc.1$116
Novartis1$69

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,351,106 in reported general payments places this provider in the 95th percentile of 669 infectious disease providers in Florida.

See all infectious disease providers in Florida

Medicare billing

Part B allowed, 2024
$7,227
Medicare patients
34
Services billed
78

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other infectious disease in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →